Cover Image
Market Research Report
Product code 
1092241

COVID-19 Rapid Antigen Test Kits Market - Global Outlook & Forecast 2022-2027

Published: | Arizton Advisory & Intelligence | 294 Pages | Delivery time: 1-2 business days

Price

Back to Top
COVID-19 Rapid Antigen Test Kits Market - Global Outlook & Forecast 2022-2027
Published: June 20, 2022
Arizton Advisory & Intelligence
Content info: 294 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The Global Covid-19 Rapid Antigen test kits market is expected to reach USD 743.07 million by 2027

Antigen tests are commonly used in the diagnosis of pathogens, including influenza viruses and respiratory syncytial viruses. These tests are immunoassays that detect specific viral antigen and confirms the presence or absence of viral infection. Rapid antigen tests are currently authorized to be performed on nasal or nasopharyngeal swab specimens placed directly into the immunoassay's extraction buffer or reagent. The currently available rapid antigen tests include point-of-care (POC) and laboratory-based tests, as well as self-tests performed at home, and they are commercially available to people of any age. A rapid antigen test is one of the widely used diagnostic tests to diagnose COVID-19 presence in an individual with or without symptoms. It offers a faster result and is relatively less expensive than PCR (polymerase chain reaction) or antibody tests.

The global COVID-19 rapid antigen tests market is a new demanding market. The market is growing at a rapid pace due to the COVID-19 pandemic and will become a normal market like other infectious diseases.

The testing plays a significant role in containing and mitigating the pandemic by identifying the infected individual and stopping further person-to-person transmission. Rapid antigen testing is one of the primarily performed COVID-19 tests globally. This diagnosis determines the portion of virus protein and can give results within 15 minutes. Initially, the PCR was considered the gold standard for COVID-19 diagnosis. However, over time, usage of rapid diagnostics kits has increased, and also, the vendors have introduced highly sensitive COVID-19 rapid tests kits.

Benefits of COVID-19 Rapid Antigen Testing

One of the significant advantages of people preferring rapid antigen testing devices is its quick results and more economic ability than other testing devices in the market. The demand for rapid COVID-19 antigen test kits is growing due to their low cost and easy use. The government in many countries is widely making the test kits available at a discounted price, which is one of the major factors boosting the adoption rate of home test kits.

Raise in Infection Spread

Multiple variants of the COVID-19 virus were identified across the globe. Governments started providing authorization for the emergency use of numerous test kits to increase access to COVID-19 tests. Countries such as the US and the UK started providing free home test kits, which has led to the high adoption of home test kits as these devices can be used without professional guidance.

Technological Advancements in COVID-19 Rapid Testing

Vendors designed various new rapid testing kits such as cups and cards and smart test kits, which were more sensitive and provided better results, almost equal to gold-standard PCR testing. There were painless rapid testing kits that used saliva samples. Test kits providing results in a shorter time were also introduced in the market. These advancements drive the usage of rapid testing over other COVID-19 testing kits. For instance, CoviFind COVID-19 Rapid Antigen Self-Test, a non-prescription product manufactured by Meril Diagnostics, an India-based, global medical company, has approval from ICMR for regular use in India self-test and is easily accessible.

Large academic institutes, and companies distributed home test kits at no cost to their stakeholders. This was a precautionary measure and peace of mind for the students and workers, helping people decide on the pandemic. Several steps are taken by the government, corporate companies, and academic institutes to increase the usage of COVID-19 rapid testing kits.

Mass Testing Strategy Among Countries & Robust Fundings for COVID-19 Testing

Robust testing strategies are seen as a significant aspect of preparedness and response to the COVID-19 pandemic, early detection of infection rates, and transmission, among others. Many countries started conducting COVID-19 mass testing strategies to reduce the spread of infections. People traveling from other countries were tested in airports, and migrating within-country required covid-19 certificates. Many were also tested on the spot using rapid test kits to reduce the spread of infections. Many NGOs, large regulatory bodies, and companies started manufacturing the COVID-19 test kits to tap the opportunity in the market. The increased investments made the companies increase their production volume. This, in turn, vastly increased the opportunities for COVID-19 rapid testing in the market.

One of the major limitations of rapid testing is the increased number of false-positive and negative results. There were cases with false-negative and false-positive reports in a set of

COVID-19 test kits. People with COVID-19 symptoms were tested negative and tested positive when checked with alternative COVID-19 testing. These instances reduced the usage of COVID-19 rapid test kits in a few countries. Some countries like China still consider using RT-PCR tests for screening people.

Developed countries like the US, Germany, the UK, France, Italy, Canada, and Spain are conducting many COVID-19 rapid tests through OTC/Home tests and healthcare settings. People in developed countries purchase home testing kits and preserve them for future use. This is not the case in developing countries. Only symptomatic people prefer buying the kits to get tested. This trend differentiates the consumption pattern among the nations. A country like Canada has ordered more rapid test kits than its population count, whereas India has not.

GLOBAL COVID-19 RAPID ANTIGEN TESTING MARKET SHARE ANALYSIS

Europe dominated the COVID-19 rapid testing market by geography segment. However, APAC is expected to grow at a faster rate. Due to the increased adoption of rapid testing and quicker approval of COVID-19 rapid home test kits in Europe, the COVID-19 rapid antigen test kits market in Europe will remain dominant. North America was the second-largest market with faster product approvals, launches, and better distribution of home test kits. The United States launched new initiatives like testing with treatments, which means the treatment is provided as soon as the person is tested positive. These kinds of initiatives will primarily drive the usage of rapid test kits in the US. Hospitals & Clinics were the most significant users in the COVID-19 antigen test market. Mainly professional rapid testing was used in the hospitals & clinics segments. Individual segments had faster Covid-19 antigen test kits market growth rates. The demand for home test kits is increasing, and many companies are investing in manufacturing large volumes as there is a surge for home test kits in the market.

Key Vendors

  • Abbott
  • BD
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories

Other Prominent Vendors

  • AccuBioTech
  • AIVD Biotech
  • AMEDA LABORDIAGNOSTIK
  • ANP Technologies
  • Angstrom Biotech
  • ARISTA Biotech
  • Assure Tech (Hangzhou)
  • Biolidics
  • BioMaxima SA
  • Biopanda Reagents
  • Biosynex
  • BIOHIT Healthcare
  • BioSpeedia
  • BioMedomics
  • BioTeke
  • BTNX
  • CTK Biotech
  • CERTEST BIOTEC
  • Celltrion
  • Chembio Diagnostics
  • Ellume
  • Empowered Diagnostics
  • FUJIFILM
  • GUANGZHOU DECHENG BIOTECHNOLOGY
  • Getein Biotech
  • GenBody
  • Hangzhou Alltest Biotech
  • Hangzhou Clongene Biotech
  • Healgen Scientific
  • Wondfo
  • KH Medical
  • Lepu Medical Technology
  • LumiraDx
  • Mylab Discovery Solutions
  • Meril Life Sciences
  • Medicofarma
  • nal von minden
  • OraSure Technologies
  • PerkinElmer
  • Quidel
  • Siemens Healthineers
  • SD Biosensor
  • Tianjin Era Biology Technology
  • Xiamen Boson Biotech
  • Zhejiang Orient Gene Biotech

Market Segmentation by Prescription

  • Professional
  • At-Home/OTC

Market Segmentation by End-User

  • Hospitals & Clinics
  • Laboratories
  • Individuals/Homecare
  • Others

Market Segmentation by Geography

  • Europe
    • UK
    • France
    • Russia
    • Italy
    • Spain
    • Germany
    • Netherland
    • Poland
  • North America
    • US
    • Canada
  • APAC
    • India
    • Australia
    • South Korea
    • Malaysia
    • China
    • Philippines
    • Japan
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa
    • Iran
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Peru
    • Columbia
    • Chile

KEY QUESTIONS ANSWERED:

  • 1. What was the size of the COVID-19 rapid antigen test kits market in 2021?
  • 2. Who are the key players in the COVID-19 rapid antigen test kits market?
  • 3. What are the growth opportunities in the Rapid Covid-19 antigen test kits market?
  • 4. What are the strategies adopted by the players in the COVID-19 rapid antigen test kits market?
  • 5. What are the growth enablers in the COVID-19 rapid antigen test kits market?
Product Code: Sample_COVID-19 Rapid Antigen Test Kits Market - Global Outlook & Forecast 2022-2027_Arizton.pdf

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
  • 4.4 MARKET SEGMENTS
    • 4.4.1 MARKET SEGMENTATION BY PRESCRIPTION
    • 4.4.2 MARKET SEGMENTATION BY END-USER
    • 4.4.3 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT GLANCE

7 INTRODUCTION

  • 7.1 BACKGROUND
    • 7.1.1 OVERVIEW
    • 7.1.2 INTRODUCTION
  • 7.2 IMPACT OF COVID-19 ON GLOBAL SUPPLY CHAIN
    • 7.2.1 IMPORTANCE OF COVID-19 TESTING

8 MARKET OPPORTUNITIES & TRENDS

  • 8.1 TECHNOLOGICAL ADVANCES IN COVID-19 RAPID TEST KITS
  • 8.2 INCREASING MASS TESTING FOR COVID-19
  • 8.3 INTRODUCTION OF COVID-19 HOME TESTING KITS

9 MARKET GROWTH ENABLERS

  • 9.1 ROBUST FUNDING & INVESTMENTS TO SCALE UP COVID-19 TEST KIT PRODUCTION
  • 9.2 INCREASED PRODUCT LAUNCHES
  • 9.3 INCREASING DONATIONS OF COVID-19 RAPID ANTIGEN TEST KITS
  • 9.4 RISING COVID-19 CASES

10 MARKET GROWTH RESTRAINTS

  • 10.1 INCREASED FALSE POSITIVE & FALSE NEGATIVE RESULTS
  • 10.2 INCREASING NON-REGULATED GENERIC TEST KITS
  • 10.3 DEFECTIVE GENERIC TEST KITS

11 MARKET LANDSCAPE

  • 11.1 MARKET OVERVIEW
  • 11.2 MARKET SIZE & FORECAST
    • 11.2.1 INSIGHTS BY PRESCRIPTION
    • 11.2.2 INSIGHTS BY END-USERS
    • 11.2.3 INSIGHTS BY GEOGRAPHY
  • 11.3 FIVE FORCES ANALYSIS
    • 11.3.1 THREAT OF NEW ENTRANTS
    • 11.3.2 BARGAINING POWER OF SUPPLIERS
    • 11.3.3 BARGAINING POWER OF BUYERS
    • 11.3.4 THREAT OF SUBSTITUTES
    • 11.3.5 COMPETITIVE RIVALRY

12 PRESCRIPTION

  • 12.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 12.2 MARKET OVERVIEW
  • 12.3 PROFESSIONAL
    • 12.3.1 MARKET OVERVIEW
    • 12.3.2 MARKET SIZE & FORECAST
    • 12.3.3 PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY
  • 12.4 AT-HOME/OTC
    • 12.4.1 MARKET OVERVIEW
    • 12.4.2 MARKET SIZE & FORECAST
    • 12.4.3 AT-HOME/OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY

13 END-USER

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 HOSPITALS & CLINICS
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
  • 13.4 LABORATORIES
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
  • 13.5 INDIVIDUALS/ HOMECARE
    • 13.5.1 MARKET OVERVIEW
    • 13.5.2 MARKET SIZE & FORECAST
  • 13.6 OTHERS
    • 13.6.1 MARKET OVERVIEW
    • 13.6.2 MARKET SIZE & FORECAST

14 GEOGRAPHY

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
    • 14.1.1 PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY
    • 14.1.2 OTC/AT-HOME COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY
  • 14.2 GEOGRAPHIC OVERVIEW

15 EUROPE

  • 15.1 MARKET OVERVIEW
  • 15.2 MARKET SIZE & FORECAST
  • 15.3 EUROPE COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 15.4 EUROPE PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 15.5 EUROPE OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 15.6 KEY COUNTRIES
    • 15.6.1 UK: MARKET SIZE & FORECAST
    • 15.6.2 FRANCE: MARKET SIZE & FORECAST
    • 15.6.3 RUSSIA: MARKET SIZE & FORECAST
    • 15.6.4 ITALY: MARKET SIZE & FORECAST
    • 15.6.5 SPAIN: MARKET SIZE & FORECAST
    • 15.6.6 GERMANY: MARKET SIZE & FORECAST
    • 15.6.7 NETHERLANDS: MARKET SIZE & FORECAST
    • 15.6.8 POLAND: MARKET SIZE & FORECAST

16 NORTH AMERICA

  • 16.1 MARKET OVERVIEW
  • 16.2 MARKET SIZE & FORECAST
  • 16.3 NORTH AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 16.4 NORTH AMERICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KIT MARKET
  • 16.5 NORTH AMERICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 16.6 KEY COUNTRIES
    • 16.6.1 US: MARKET SIZE & FORECAST
    • 16.6.2 CANADA: MARKET SIZE & FORECAST

17 APAC

  • 17.1 MARKET OVERVIEW
  • 17.2 MARKET SIZE & FORECAST
  • 17.3 APAC COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 17.4 APAC PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 17.5 APAC OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 17.6 KEY COUNTRIES
    • 17.6.1 INDIA: MARKET SIZE & FORECAST
    • 17.6.2 AUSTRALIA: MARKET SIZE & FORECAST
    • 17.6.3 SOUTH KOREA: MARKET SIZE & FORECAST
    • 17.6.4 MALAYSIA: MARKET SIZE & FORECAST
    • 17.6.5 CHINA: MARKET SIZE & FORECAST
    • 17.6.6 PHILIPPINES: MARKET SIZE & FORECAST
    • 17.6.7 JAPAN: MARKET SIZE & FORECAST

18 MIDDLE EAST & AFRICA

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
  • 18.3 MIDDLE EAST &AFRICA COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 18.4 MIDDLE EAST &AFRICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 18.5 MIDDLE EAST &AFRICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 18.6 KEY COUNTRIES
    • 18.6.1 TURKEY: MARKET SIZE & FORECAST
    • 18.6.2 SAUDI ARABIA: MARKET SIZE & FORECAST
    • 18.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST
    • 18.6.4 IRAN: MARKET SIZE & FORECAST

19 LATIN AMERICA

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
  • 19.3 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 19.4 LATIN AMERICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 19.5 LATIN AMERICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 19.6 KEY COUNTRIES
    • 19.6.1 BRAZIL: MARKET SIZE & FORECAST
    • 19.6.2 MEXICO: MARKET SIZE & FORECAST
    • 19.6.3 ARGENTINA: MARKET SIZE & FORECAST
    • 19.6.4 PERU: MARKET SIZE & FORECAST
    • 19.6.5 COLOMBIA: MARKET SIZE & FORECAST
    • 19.6.6 CHILE: MARKET SIZE & FORECAST

20 COMPETITIVE LANDSCAPE

  • 20.1 COMPETITION OVERVIEW
  • 20.2 MARKET SHARE ANALYSIS
    • 20.2.1 ABBOTT
    • 20.2.2 BD
    • 20.2.3 F.HOFFMANN-LA ROCHE
    • 20.2.4 THERMO FISHER SCIENTIFIC
    • 20.2.5 BIO-RAD LABORATORIES

21 KEY COMPANY PROFILES

  • 21.1 ABBOTT
    • 21.1.1 BUSINESS OVERVIEW
    • 21.1.2 PRODUCT OFFERINGS
    • 21.1.3 KEY STRATEGIES
    • 21.1.4 KEY STRENGTHS
    • 21.1.5 KEY OPPORTUNITIES
  • 21.2 BD
    • 21.2.1 BUSINESS OVERVIEW
    • 21.2.2 PRODUCT OFFERINGS
    • 21.2.3 KEY STRATEGIES
    • 21.2.4 KEY STRENGTHS
    • 21.2.5 KEY OPPORTUNITIES
  • 21.3 F.HOFFMANN-LA ROCHE
    • 21.3.1 BUSINESS OVERVIEW
    • 21.3.2 PRODUCT OFFERINGS
    • 21.3.3 KEY STRATEGIES
    • 21.3.4 KEY STRENGTHS
    • 21.3.5 KEY OPPORTUNITIES
  • 21.4 THERMO FISHER SCIENTIFIC
    • 21.4.1 BUSINESS OVERVIEW
    • 21.4.2 PRODUCT OFFERINGS
    • 21.4.3 KEY STRATEGIES
    • 21.4.4 KEY STRENGTHS
    • 21.4.5 KEY OPPORTUNITIES
  • 21.5 BIO-RAD LABORATORIES
    • 21.5.1 BUSINESS OVERVIEW
    • 21.5.2 PRODUCT OFFERINGS
    • 21.5.3 KEY STRATEGIES
    • 21.5.4 KEY STRENGTHS
    • 21.5.5 KEY OPPORTUNITIES

22 OTHER PROMINENT VENDORS

  • 22.1 ACCUBIOTECH
    • 22.1.1 BUSINESS OVERVIEW
    • 22.1.2 PRODUCT OFFERINGS
  • 22.2 AIVD BIOTECH
    • 22.2.1 BUSINESS OVERVIEW
    • 22.2.2 PRODUCT OFFERINGS
  • 22.3 AMEDA LABORDIAGNOSTIK
    • 22.3.1 BUSINESS OVERVIEW
    • 22.3.2 PRODUCT OFFERINGS
  • 22.4 ANP TECHNOLOGIES
    • 22.4.1 BUSINESS OVERVIEW
    • 22.4.2 PRODUCT OFFERINGS
  • 22.5 ANGSTROM BIOTECH
    • 22.5.1 BUSINESS OVERVIEW
    • 22.5.2 PRODUCT OFFERINGS
  • 22.6 ARISTA BIOTECH
    • 22.6.1 BUSINESS OVERVIEW
    • 22.6.2 PRODUCT OFFERINGS
  • 22.7 ASSURE TECH (HANGZHOU)
    • 22.7.1 BUSINESS OVERVIEW
    • 22.7.2 PRODUCT OFFERINGS
  • 22.8 BIOLIDICS
    • 22.8.1 BUSINESS OVERVIEW
    • 22.8.2 PRODUCT OFFERINGS
  • 22.9 BIOMAXIMA
    • 22.9.1 BUSINESS OVERVIEW
    • 22.9.2 PRODUCT OFFERINGS
  • 22.10 BIOPANDA REAGENTS
    • 22.10.1 BUSINESS OVERVIEW
    • 22.10.2 PRODUCT OFFERINGS
  • 22.11 BIOSYNEX
    • 22.11.1 BUSINESS OVERVIEW
    • 22.11.2 PRODUCT OFFERINGS
  • 22.12 BIOHIT HEALTHCARE (HEFEI)
    • 22.12.1 BUSINESS OVERVIEW
    • 22.12.2 PRODUCT OFFERINGS
  • 22.13 BIOSPEEDIA
    • 22.13.1 BUSINESS OVERVIEW
    • 22.13.2 PRODUCT OFFERINGS
  • 22.14 BIOMEDOMICS
    • 22.14.1 BUSINESS OVERVIEW
    • 22.14.2 PRODUCT OFFERINGS
  • 22.15 BIOTEKE (WUXI)
    • 22.15.1 BUSINESS OVERVIEW
    • 22.15.2 PRODUCT OFFERINGS
  • 22.16 BTNX
    • 22.16.1 BUSINESS OVERVIEW
    • 22.16.2 PRODUCT OFFERINGS
  • 22.17 CTK BIOTECH
    • 22.17.1 BUSINESS OVERVIEW
    • 22.17.2 PRODUCT OFFERINGS
  • 22.18 CERTEST BIOTEC
    • 22.18.1 BUSINESS OVERVIEW
    • 22.18.2 PRODUCT OFFERINGS
  • 22.19 CELLTRION
    • 22.19.1 BUSINESS OVERVIEW
    • 22.19.2 PRODUCT OFFERINGS
  • 22.20 CHEMBIO DIAGNOSTICS
    • 22.20.1 BUSINESS OVERVIEW
    • 22.20.2 PRODUCT OFFERINGS
  • 22.21 ELLUME
    • 22.21.1 BUSINESS OVERVIEW
    • 22.21.2 PRODUCT OFFERINGS
  • 22.22 EMPOWERED DIAGNOSTICS
    • 22.22.1 BUSINESS OVERVIEW
    • 22.22.2 PRODUCT OFFERINGS
  • 22.23 FUJIFILM
    • 22.23.1 BUSINESS OVERVIEW
    • 22.23.2 PRODUCT OFFERINGS
  • 22.24 GUANGZHOU DECHENG BIOTECHNOLOGY
    • 22.24.1 BUSINESS OVERVIEW
    • 22.24.2 PRODUCT OFFERINGS
  • 22.25 GETEIN BIOTECH
    • 22.25.1 BUSINESS OVERVIEW
    • 22.25.2 PRODUCT OFFERINGS
  • 22.26 GENBODY
    • 22.26.1 BUSINESS OVERVIEW
    • 22.26.2 PRODUCT OFFERINGS
  • 22.27 HANGZHOU ALLTEST BIOTECH
    • 22.27.1 BUSINESS OVERVIEW
    • 22.27.2 PRODUCT OFFERINGS
  • 22.28 HANGZHOU CLONGENE BIOTECH
    • 22.28.1 BUSINESS OVERVIEW
    • 22.28.2 PRODUCT OFFERINGS
  • 22.29 HEALGEN SCIENTIFIC
    • 22.29.1 BUSINESS OVERVIEW
    • 22.29.2 PRODUCT OFFERINGS
  • 22.30 KH MEDICAL
    • 22.30.1 BUSINESS OVERVIEW
    • 22.30.2 PRODUCT OFFERINGS
  • 22.31 LEPU MEDICAL TECHNOLOGY (BEIJING)
    • 22.31.1 BUSINESS OVERVIEW
    • 22.31.2 PRODUCT OFFERINGS
  • 22.32 LUMIRADX
    • 22.32.1 BUSINESS OVERVIEW
    • 22.32.2 PRODUCT OFFERINGS
  • 22.33 MYLAB DISCOVERY SOLUTIONS
    • 22.33.1 BUSINESS OVERVIEW
    • 22.33.2 PRODUCT OFFERINGS
  • 22.34 MERIL LIFE SCIENCES
    • 22.34.1 BUSINESS OVERVIEW
    • 22.34.2 PRODUCT OFFERINGS
  • 22.35 MEDICOFARMA
    • 22.35.1 BUSINESS OVERVIEW
    • 22.35.2 PRODUCT OFFERINGS
  • 22.36 NAL VON MINDEN
    • 22.36.1 BUSINESS OVERVIEW
    • 22.36.2 PRODUCT OFFERINGS
  • 22.37 ORASURE TECHNOLOGIES
    • 22.37.1 BUSINESS OVERVIEW
    • 22.37.2 PRODUCT OFFERINGS
  • 22.38 PERKINELMER
    • 22.38.1 BUSINESS OVERVIEW
    • 22.38.2 PRODUCT OFFERINGS
  • 22.39 QUIDEL
    • 22.39.1 BUSINESS OVERVIEW
    • 22.39.2 PRODUCT OFFERINGS
  • 22.40 SIEMENS HEALTHINEERS
    • 22.40.1 BUSINESS OVERVIEW
    • 22.40.2 PRODUCT OFFERINGS
  • 22.41 SD BIOSENSOR
    • 22.41.1 BUSINESS OVERVIEW
    • 22.41.2 PRODUCT OFFERINGS
  • 22.42 TIANJIN ERA BIOLOGY TECHNOLOGY
    • 22.42.1 BUSINESS OVERVIEW
    • 22.42.2 PRODUCT OFFERINGS
  • 22.43 XIAMEN BOSON BIOTECH
    • 22.43.1 BUSINESS OVERVIEW
    • 22.43.2 PRODUCT OFFERINGS
  • 22.44 WONDFO
    • 22.44.1 BUSINESS OVERVIEW
    • 22.44.2 PRODUCT OFFERINGS
  • 22.45 ZHEJIANG ORIENT GENE BIOTECH
    • 22.45.1 BUSINESS OVERVIEW
    • 22.45.2 PRODUCT OFFERINGS

23 REPORT SUMMARY

  • 23.1 KEY TAKEAWAYS
  • 23.2 STRATEGIC RECOMMENDATIONS

24 QUANTITATIVE SUMMARY

  • 24.1 MARKET BY GEOGRAPHY
  • 24.2 MARKET BY PRESCRIPTION
  • 24.3 MARKET BY END-USER
  • 24.4 NORTH AMERICA: PROFESSIONAL
  • 24.5 NORTH AMERICA: OTC
  • 24.6 NORTH AMERICA: COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 24.7 EUROPE: PROFESSIONAL
  • 24.8 EUROPE: OTC
  • 24.9 EUROPE: COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 24.10 APAC: PROFESSIONAL
  • 24.11 APAC: OTC
  • 24.12 APAC: COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 24.13 LATIN AMERICA: PROFESSIONAL
  • 24.14 LATIN AMERICA: OTC
  • 24.15 LATIN AMERICA: COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • 24.16 MIDDLE EAST& AFRICA: PROFESSIONAL
  • 24.17 MIDDLE EAST& AFRICA: OTC
  • 24.18 MIDDLE EAST& AFRICA: COVID-19 RAPID ANTIGEN TEST KITS MARKET

25 APPENDIX

  • 25.1 ABBREVIATIONS

LIST OF EXHIBITS

  • EXHIBIT 1 SEGMENTATION OF GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET
  • EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
  • EXHIBIT 3 COVID-19 RAPID ANTIGEN TEST KITS SUPPLY CHAIN ANALYSIS
  • EXHIBIT 4 IMPACT OF TECHNOLOGICAL ADVANCES IN COVID-19 RAPID TEST KITS
  • EXHIBIT 5 IMPACT OF INCREASING MASS TESTING FOR COVID-19
  • EXHIBIT 6 IMPACT OF INTRODUCTION OF COVID-19 HOME TESTING KITS
  • EXHIBIT 7 IMPACT OF ROBUST FUNDING AND INVESTMENTS TO SCALE UP COVID-19 TEST KIT PRODUCTION
  • EXHIBIT 8 DISTRIBUTION OF COVID-19 RAPID ANTIGEN TESTS IN US (IN MILLION)
  • EXHIBIT 9 IMPACT OF INCREASED PRODUCT LAUNCHES
  • EXHIBIT 10 IMPACT OF INCREASING DONATIONS OF COVID-19 RAPID ANTIGEN TEST KITS
  • EXHIBIT 11 IMPACT OF RISING COVID-19 CASES
  • EXHIBIT 12 CONFIRMED COVID-19 CASES BY REGION (MILLION)
  • EXHIBIT 13 IMPACT OF INCREASED FALSE POSITIVE & FALSE NEGATIVE RESULTS
  • EXHIBIT 14 ALGORITHM FOR COVID-19 TEST INTERPRETATION USING RAPID ANTIGEN POINT-OF-CARE TEST
  • EXHIBIT 15 IMPACT OF INCREASING NON-REGULATED GENERIC TEST KITS
  • EXHIBIT 16 IMPACT OF DEFECTIVE GENERIC TEST KITS
  • EXHIBIT 17 COVID-19 WAVES & NEW VARIANT EVOLUTION
  • EXHIBIT 18 GLOBAL COVID-19 RAPID ANTIGEN TESTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 19 GLOBAL PRESCRIPTION COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021 & 2027 (%)
  • EXHIBIT 20 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY END-USER 2021 & 2027 (%)
  • EXHIBIT 21 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY 2021 & 2027 (%)
  • EXHIBIT 22 FIVE FORCES ANALYSIS 2021
  • EXHIBIT 23 INCREMENTAL GROWTH BY PRESCRIPTION 2021 & 2027
  • EXHIBIT 24 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY PRESCRIPTION
  • EXHIBIT 25 GLOBAL COVID-19 RAPID ANTIGEN TESTS MARKET BY PRESCRIPTION: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 26 GLOBAL COVID-19 RAPID ANTIGEN TESTS MARKET BY PRESCRIPTION: ABSOLUTE GROWTH (%)
  • EXHIBIT 27 GLOBAL PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 28 GLOBAL PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 29 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 30 GLOBAL AT-HOME/OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 31 GLOBAL AT-HOME/OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 32 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 33 INCREMENTAL GROWTH BY END-USER 2021 & 2027
  • EXHIBIT 34 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY END-USER
  • EXHIBIT 35 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY END-USER: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 36 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY END-USER: ABSOLUTE GROWTH (%)
  • EXHIBIT 37 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY HOSPITALS & CLINICS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 38 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY HOSPITALS & CLINICS 2021-2027 ($ MILLION)
  • EXHIBIT 39 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY LABORATORIES: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 40 GLOBAL COVID-19 RAPID ANTIGEN TESTS MARKET BY LABORATORIES 2021-2027 ($ MILLION)
  • EXHIBIT 41 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY INDIVIDUALS/HOMECARE: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 42 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY INDIVIDUALS/HOME CARE 2021-2027 ($ MILLION)
  • EXHIBIT 43 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY OTHER END-USERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 44 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY OTHER END-USERS 2021-2027 ($ MILLION)
  • EXHIBIT 45 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 46 INCREMENTAL GROWTH BY PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS 2021 & 2027
  • EXHIBIT 47 OTC/AT-HOME COVID-19 RAPID ANTIGEN TEST KITS MARKET: INCREMENTAL GROWTH 2021 & 2027
  • EXHIBIT 48 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY
  • EXHIBIT 49 SHARE OF COUNTRIES IN MANUFACTURING COVID-19 RAPID ANTIGEN TESTS KITS
  • EXHIBIT 50 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 51 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)
  • EXHIBIT 52 EUROPE COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 53 EUROPE COVID-19 RAPID ANTIGEN TEST KITS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 54 EUROPE COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 55 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
  • EXHIBIT 56 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN UK 2021-2027 ($ MILLION)
  • EXHIBIT 57 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN FRANCE 2021-2027 ($ MILLION)
  • EXHIBIT 58 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN RUSSIA 2021-2027 ($ MILLION)
  • EXHIBIT 59 COVID-19 RAPID ANTIGEN TESTS MARKET IN ITALY 2021-2027 ($ MILLION)
  • EXHIBIT 60 COVID-19 RAPID ANTIGEN TESTS MARKET IN SPAIN 2021-2027 ($ MILLION)
  • EXHIBIT 61 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN GERMANY 2021-2027 ($ MILLION)
  • EXHIBIT 62 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN NETHERLANDS 2021-2027 ($ MILLION)
  • EXHIBIT 63 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN POLAND 2021-2027 ($ MILLION)
  • EXHIBIT 64 US COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 65 NORTH AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 66 NORTH AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 67 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
  • EXHIBIT 68 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN US 2021-2027 ($ MILLION)
  • EXHIBIT 69 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN CANADA 2021-2027 ($ MILLION)
  • EXHIBIT 70 APAC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 71 APAC COVID-19 RAPID ANTIGEN TEST KITS MARKET: INCREMENTAL & ABSOLUTE GROWTH ($ MILLION)
  • EXHIBIT 72 APAC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 73 INCREMENTAL GROWTH IN APAC 2021 & 2027
  • EXHIBIT 74 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN INDIA 2021-2027 ($ MILLION)
  • EXHIBIT 75 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN AUSTRALIA 2021-2027 ($ MILLION)
  • EXHIBIT 76 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN SOUTH KOREA 2021-2027 ($ MILLION)
  • EXHIBIT 77 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN MALAYSIA 2021-2027 ($ MILLION)
  • EXHIBIT 78 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN CHINA 2021-2027 ($ MILLION)
  • EXHIBIT 79 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN PHILIPPINES 2021-2027 ($ MILLION)
  • EXHIBIT 80 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN JAPAN 2021-2027 ($ MILLION)
  • EXHIBIT 81 MIDDLE EAST & AFRICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 82 MIDDLE EAST & AFRICA COVID-19 RAPID ANTIGEN TEST KITS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 83 MIDDLE EAST & AFRICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 84 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
  • EXHIBIT 85 COVID-19 RAPID ANTIGEN TESTS MARKET IN TURKEY 2021-2027 ($ MILLION)
  • EXHIBIT 86 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN SAUDI ARABIA 2021-2027 ($ MILLION)
  • EXHIBIT 87 SOUTH AFRICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 88 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN IRAN 2021-2027 ($ MILLION)
  • EXHIBIT 89 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 90 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 91 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 92 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
  • EXHIBIT 93 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN BRAZIL 2021-2027 ($ MILLION)
  • EXHIBIT 94 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN MEXICO 2021-2027 ($ MILLION)
  • EXHIBIT 95 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN ARGENTINA 2021-2027 ($ MILLION)
  • EXHIBIT 96 DISTRIBUTION OF COVID-19 TESTS TILL SEPTEMBER 2021
  • EXHIBIT 97 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN PERU 2021-2027 ($ MILLION)
  • EXHIBIT 98 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN COLOMBIA 2021-2027 ($ MILLION)
  • EXHIBIT 99 COVID-19 RAPID ANTIGEN TEST KITS MARKET IN CHILE 2021-2027 ($ MILLION)
  • EXHIBIT 100 ABBOTT: TOTAL REVENUE 2018-2020 ($ MILLION)
  • EXHIBIT 101 ABBOTT: R&D EXPENDITURE 2018-2020 ($ MILLION)
  • EXHIBIT 102 ABBOTT REVENUE BY RAPID DIAGNOSTIC SEGMENTS 2018-2020 ($ MILLION)
  • EXHIBIT 103 BD: TOTAL REVENUE 2019-2021 ($ MILLION)
  • EXHIBIT 104 BD: R&D EXPENDITURE 2019-2021 ($ MILLION)
  • EXHIBIT 105 BD: REVENUE BY INTEGRATED DIAGNOSTIC SOLUTIONS SEGMENT 2019-2021 ($ MILLION)
  • EXHIBIT 106 F.HOFFMANN-LA ROCHE: TOTAL REVENUE 2018-2020 ($ MILLION)
  • EXHIBIT 107 F.HOFFMANN-LA ROCHE: R&D EXPENDITURE 2018-2020 ($ MILLION)
  • EXHIBIT 108 F.HOFFMANN-LA ROCHE: REVENUE BY DIAGNOSTICS SEGMENT ($ MILLION)
  • EXHIBIT 109 F.HOFFMANN-LA ROCHE: MARKET SHARE BY GEOGRAPHY 2020 (DIAGNOSTICS SEGMENT)
  • EXHIBIT 110 THERMO FISHER SCIENTIFIC: TOTAL REVENUE 2018-2020 ($ MILLION)
  • EXHIBIT 111 THERMO FISHER SCIENTIFIC: R&D EXPENDITURE 2018-2020 ($ MILLION)
  • EXHIBIT 112 THERMO FISHER SCIENTIFIC: REVENUE BY SPECIALTY DIAGNOSTICS SEGMENT ($ MILLION)
  • EXHIBIT 113 BIO-RAD LABORATORIES: TOTAL REVENUE 2018-2020 ($ MILLION)
  • EXHIBIT 114 BIO-RAD LABORATORIES: R&D EXPENDITURE 2018-2020 ($ MILLION)

LIST OF TABLES

  • TABLE 1 KEY CAVEATS
  • TABLE 2 CURRENCY CONVERSION 2015-2021
  • TABLE 3 FIRST APPROVAL OF HOME-BASED COVID-19 RAPID TEST KITS
  • TABLE 4 LIST OF ICMR APPROVED COVID-19 HOME RAPID ANTIGEN TEST KITS
  • TABLE 5 VENDORS WITH NIH PROJECTS FOR DEVELOPING RAPID ANTIGEN TEST KITS
  • TABLE 6 COVID-19 RAPID ANTIGEN TEST KITS LAUNCHED DURING 2020-2022
  • TABLE 7 TOP 10 COUNTRIES WITH HIGH COVID-19 CASES (MILLION)
  • TABLE 8 COVID-19 RAPID ANTIGEN TESTS FOR PROFESSIONAL USE
  • TABLE 9 COVID-19 RAPID ANTIGEN TESTS FOR HOME/OTC USE
  • TABLE 10 EUROPE COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 11 EUROPE COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 (%)
  • TABLE 12 EUROPE PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 13 EUROPE PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 (%)
  • TABLE 14 EUROPE OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 15 EUROPE OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 (%)
  • TABLE 16 NORTH AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 17 NORTH AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 (%)
  • TABLE 18 NORTH AMERICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 19 NORTH AMERICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 (%)
  • TABLE 20 NORTH AMERICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 21 NORTH AMERICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 (%)
  • TABLE 22 GOVERNMENT AGREEMENTS WITH COVID-19 RAPID ANTIGEN TEST KIT SUPPLIERS
  • TABLE 23 APAC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 24 APAC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 (%)
  • TABLE 25 APAC PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 26 APAC PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027(%)
  • TABLE 27 APAC OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 28 APAC OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027(%)
  • TABLE 29 MIDDLE EAST & AFRICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 30 MIDDLE EAST & AFRICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 (%)
  • TABLE 31 MIDDLE EAST & AFRICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 32 MIDDLE EAST & AFRICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 (%)
  • TABLE 33 MIDDLE EAST & AFRICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 34 MIDDLE EAST & AFRICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 (%)
  • TABLE 35 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 36 LATIN AMERICA COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 (%)
  • TABLE 37 LATIN AMERICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 38 LATIN AMERICA PROFESSIONAL COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 (%)
  • TABLE 39 LATIN AMERICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 40 LATIN AMERICA OTC COVID-19 RAPID ANTIGEN TEST KITS MARKET 2021-2027 (%)
  • TABLE 41 ABBOTT: MAJOR PRODUCT OFFERINGS
  • TABLE 42 BD: MAJOR PRODUCT OFFERINGS
  • TABLE 43 F.HOFFMANN-LA ROCHE: MAJOR PRODUCT OFFERINGS
  • TABLE 44 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
  • TABLE 45 BIO-RAD LABORATORIES: MAJOR PRODUCT OFFERINGS
  • TABLE 46 ACCUBIOTECH: MAJOR PRODUCT OFFERINGS
  • TABLE 47 AIVD BIOTECH: MAJOR PRODUCT OFFERINGS
  • TABLE 48 AMEDA LABORDIAGNOSTIK: MAJOR PRODUCT OFFERINGS
  • TABLE 49 ANP TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
  • TABLE 50 ANGSTROM BIOTECH: MAJOR PRODUCT OFFERINGS
  • TABLE 51 ARISTA BIOTECH: MAJOR PRODUCT OFFERINGS
  • TABLE 52 ASSURE TECH (HANGZHOU): MAJOR PRODUCT OFFERINGS
  • TABLE 53 BIOLIDICS: MAJOR PRODUCT OFFERINGS
  • TABLE 54 BIOMAXIMA: MAJOR PRODUCT OFFERINGS
  • TABLE 55 BIOPANDA REAGENTS: MAJOR PRODUCT OFFERINGS
  • TABLE 56 BIOSYNEX: MAJOR PRODUCT OFFERINGS
  • TABLE 57 BIOHIT HEALTHCARE (HEFEI): MAJOR PRODUCT OFFERINGS
  • TABLE 58 BIOSPEEDIA: MAJOR PRODUCT OFFERINGS
  • TABLE 59 BIOMEDOMICS: MAJOR PRODUCT OFFERINGS
  • TABLE 60 BIOTEKE: MAJOR PRODUCT OFFERINGS
  • TABLE 61 BTNX: MAJOR PRODUCT OFFERINGS
  • TABLE 62 CTK BIOTECH: MAJOR PRODUCT OFFERINGS
  • TABLE 63 CERTEST BIOTEC: MAJOR PRODUCT OFFERINGS
  • TABLE 64 CELLTRION: MAJOR PRODUCT OFFERINGS
  • TABLE 65 CHEMBIO DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
  • TABLE 66 ELLUME: MAJOR PRODUCT OFFERINGS
  • TABLE 67 EMPOWERED DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
  • TABLE 68 FUJIFILM: MAJOR PRODUCT OFFERINGS
  • TABLE 69 GUANGZHOU DECHENG BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
  • TABLE 70 GETEIN BIOTECH: MAJOR PRODUCT OFFERINGS
  • TABLE 71 GENBODY: MAJOR PRODUCT OFFERINGS
  • TABLE 72 HANGZHOU ALLTEST BIOTECH: MAJOR PRODUCT OFFERINGS
  • TABLE 73 HANGZHOU CLONGENE BIOTECH: MAJOR PRODUCT OFFERINGS
  • TABLE 74 HEALGEN SCIENTIFIC: MAJOR PRODUCT OFFERINGS
  • TABLE 75 KH MEDICAL: MAJOR PRODUCT OFFERINGS
  • TABLE 76 LEPU MEDICAL TECHNOLOGY (BEIJING): MAJOR PRODUCT OFFERINGS
  • TABLE 77 LUMIRADX: MAJOR PRODUCT OFFERINGS
  • TABLE 78 MYLAB DISCOVERY SOLUTIONS: MAJOR PRODUCT OFFERINGS
  • TABLE 79 MERIL LIFE SCIENCES: MAJOR PRODUCT OFFERINGS
  • TABLE 80 MEDICOFARMA: MAJOR PRODUCT OFFERINGS
  • TABLE 81 NAL VON MINDEN: MAJOR PRODUCT OFFERINGS
  • TABLE 82 ORASURE TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
  • TABLE 83 PERKINELMER: MAJOR PRODUCT OFFERINGS
  • TABLE 84 QUIDEL: MAJOR PRODUCT OFFERINGS
  • TABLE 85 SIEMENS HEALTHINEERS: MAJOR PRODUCT OFFERINGS
  • TABLE 86 SD BIOSENSOR: MAJOR PRODUCT OFFERINGS
  • TABLE 87 TIANJIN ERA BIOLOGY TECHNOLOGY: MAJOR PRODUCT OFFERINGS
  • TABLE 88 XIAMEN BOSON BIOTECH: MAJOR PRODUCT OFFERINGS
  • TABLE 89 WONDFO: MAJOR PRODUCT OFFERINGS
  • TABLE 90 ZHEJIANG ORIENT GENE BIOTECH: MAJOR PRODUCT OFFERINGS
  • TABLE 91 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 92 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 93 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY PRESCRIPTION 2021-2027 ($ MILLION)
  • TABLE 94 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY PRESCRIPTION 2021-2027 (%)
  • TABLE 95 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 96 GLOBAL COVID-19 RAPID ANTIGEN TEST KITS MARKET BY END-USER 2021-2027 (%)
  • TABLE 97 NORTH AMERICA PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 98 NORTH AMERICA PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021-2027 (%)
  • TABLE 99 NORTH AMERICA OTC COVID-19 RAPID TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 100 NORTH AMERICA OTC COVID-19 RAPID TEST KITS MARKET 2021-2027 (%)
  • TABLE 101 NORTH AMERICA COVID-19 RAPID TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 102 NORTH AMERICA COVID-19 RAPID TEST KITS MARKET 2021-2027 (%)
  • TABLE 103 EUROPE COVID-19 RAPID TEST KITS MARKET BY PROFESSIONAL 2021-2027 ($ MILLION)
  • TABLE 104 EUROPE PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021-2027 (%)
  • TABLE 105 EUROPE OTC COVID-19 RAPID TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 106 EUROPE OTC COVID-19 RAPID TEST KITS MARKET 2021-2027 (%)
  • TABLE 107 EUROPE COVID-19 RAPID TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 108 EUROPE COVID-19 RAPID TEST KITS MARKET 2021-2027 (%)
  • TABLE 109 APAC PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 110 APAC PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021-2027 (%)
  • TABLE 111 APAC OTC COVID-19 RAPID TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 112 APAC OTC COVID-19 RAPID TEST KITS MARKET 2021-2027 (%)
  • TABLE 113 APAC COVID-19 RAPID TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 114 APAC COVID-19 RAPID TEST KITS MARKET 2021-2027 (%)
  • TABLE 115 LATIN AMERICA PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 116 LATIN AMERICA PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021-2027 (%)
  • TABLE 117 LATIN AMERICA OTC COVID-19 RAPID TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 118 LATIN AMERICA OTC COVID-19 RAPID TEST KITS MARKET 2021-2027 (%)
  • TABLE 119 LATIN AMERICA COVID-19 RAPID TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 120 LATIN AMERICA COVID-19 RAPID TEST KITS MARKET 2021-2027 (%)
  • TABLE 121 MIDDLE EAST& AFRICA PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 122 MIDDLE EAST & AFRICA PROFESSIONAL COVID-19 RAPID TEST KITS MARKET 2021-2027 (%)
  • TABLE 123 MIDDLE EAST & AFRICA OTC COVID-19 RAPID TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 124 MIDDLE EAST & AFRICA OTC COVID-19 RAPID TEST KITS MARKET 2021-2027 (%)
  • TABLE 125 MIDDLE EAST& AFRICA COVID-19 RAPID TEST KITS MARKET 2021-2027 ($ MILLION)
  • TABLE 126 MIDDLE EAST &AFRICA COVID-19 RAPID TEST KITS MARKET 2021-2027 (%)